Form EFFECT Inhibrx Biosciences,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 18, 2025 |
| Accession Number: | 0002007919-25-000051 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Man Group PLC : Form 8.3 - Gamma Communications Plc
- Goldhills Holding Ltd Closes Private Placement
- RETRANSMISSION: HIVE Announces Upsizing and Pricing of Private Offering of US$115 Million of 0% Exchangeable Senior Notes due 2031
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
